109 related articles for article (PubMed ID: 22074280)
1. Anticoagulant counter ion impact on bioanalytical LC-MS/MS assay performance: additional validation required?
Sennbro CJ; Knutsson M; Timmerman P; van Amsterdam P
Bioanalysis; 2011 Nov; 3(21):2389-91. PubMed ID: 22074280
[No Abstract] [Full Text] [Related]
2. Anticoagulant counter ion impact on bioanalytical LC-MS/MS assays: results from discussions and experiments within the European Bioanalysis Forum.
Sennbro CJ; Knutsson M; van Amsterdam P; Timmerman P
Bioanalysis; 2011 Nov; 3(21):2393-9. PubMed ID: 22074281
[TBL] [Abstract][Full Text] [Related]
3. Confirmation of no impact from different anticoagulant counter ions on bioanalytical method.
Bergeron A; Bergeron M; Garofolo F
Bioanalysis; 2012 May; 4(8):897-908. PubMed ID: 22533564
[TBL] [Abstract][Full Text] [Related]
4. Validation of an LC-MS/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma.
Baldelli S; Cattaneo D; Pignatelli P; Perrone V; Pastori D; Radice S; Violi F; Clementi E
Bioanalysis; 2016 Feb; 8(4):275-83. PubMed ID: 26808218
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of HILIC-ESI/MS/MS methods for simultaneous quantitation of several antipsychotics in human plasma and blood.
De Meulder M; Waldron MP; Li L; Peay MG; Tingler MJ; Hidy BJ; Verhaeghe T; Jenkins RG
Bioanalysis; 2016 Apr; 8(8):765-94. PubMed ID: 27005848
[TBL] [Abstract][Full Text] [Related]
6. EBF: reflection on bioanalytical assay requirements used to support liquid microsampling.
White S; Hawthorne G; Dillen L; Spooner N; Woods K; Sangster T; Cobb Z; Timmerman P
Bioanalysis; 2014; 6(19):2581-6. PubMed ID: 25411700
[No Abstract] [Full Text] [Related]
7. Validation of an ultrasensitive LC-MS/MS method for PTH 1-34 in porcine plasma to support a solid dose PK study.
Kay RG; Hands JT; Hawthorne G; Constable S; Grosvenor M; Sharman JA
Bioanalysis; 2015; 7(12):1435-45. PubMed ID: 26168251
[TBL] [Abstract][Full Text] [Related]
8. Impact of plasma and whole-blood anticoagulant counter ion choice on drug stability and matrix effects during bioanalysis.
Bergeron M; Bergeron A; Furtado M; Garofolo F
Bioanalysis; 2009 Jun; 1(3):537-48. PubMed ID: 21083151
[TBL] [Abstract][Full Text] [Related]
9. Validating regulatory-compliant wide dynamic range bioanalytical assays using chip-based nanoelectrospray tandem mass spectrometry.
Wickremsinhe ER; Ackermann BL; Chaudhary AK
Rapid Commun Mass Spectrom; 2005; 19(1):47-56. PubMed ID: 15570573
[TBL] [Abstract][Full Text] [Related]
10. Quantification of linezolid in serum by LC-MS/MS using semi-automated sample preparation and isotope dilution internal standardization.
Zander J; Maier B; Zoller M; Teupser D; Vogeser M
Clin Chem Lab Med; 2014 Mar; 52(3):381-9. PubMed ID: 24158423
[TBL] [Abstract][Full Text] [Related]
11. Core-shell LC-MS/MS method for quantification of second generation anticoagulant rodenticides diastereoisomers in rat liver in relationship with exposure of wild rats.
Fourel I; Damin-Pernik M; Benoit E; Lattard V
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1041-1042():120-132. PubMed ID: 28033586
[TBL] [Abstract][Full Text] [Related]
12. Analytical validation of the Roche 25-OH Vitamin D Total assay.
Knudsen CS; Nexo E; Højskov CS; Heickendorff L
Clin Chem Lab Med; 2012 Nov; 50(11):1965-8. PubMed ID: 23093282
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an LC-MS/MS assay for the quantitation of a PEGylated anti-CD28 domain antibody in human serum: overcoming interference from antidrug antibodies and soluble target.
Gong C; Zeng J; Akinsanya B; Jiang H; Mora J; Chilewski S; Gambardella J; Allentoff A; Gleason C; Aubry AF; DeSilva BS; Arnold ME
Bioanalysis; 2014 Sep; 6(18):2371-83. PubMed ID: 25384590
[TBL] [Abstract][Full Text] [Related]
14. Esterase inhibitors as ester-containing drug stabilizers and their hydrolytic products: potential contributors to the matrix effects on bioanalysis by liquid chromatography/tandem mass spectrometry.
Zheng N; Fung EN; Buzescu A; Arnold ME; Zeng J
Rapid Commun Mass Spectrom; 2012 Jun; 26(11):1291-304. PubMed ID: 22555922
[TBL] [Abstract][Full Text] [Related]
15. Challenges of developing a bioanalytical method for a macrolide immunosuppressant compound by LC-MS/MS.
Taillon MP; Furtado M; Garofolo F
Bioanalysis; 2011 Jun; 3(11):1201-15. PubMed ID: 21649497
[TBL] [Abstract][Full Text] [Related]
16. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
17. A strategy for high-throughput analysis of levosimendan and its metabolites in human plasma samples using sequential negative and positive ionization liquid chromatography/tandem mass spectrometric detection.
Zhang J; Gage EM; Ji QC; El-Shourbagy TA
Rapid Commun Mass Spectrom; 2007; 21(14):2169-76. PubMed ID: 17631672
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a method using supported liquid extraction for aldosterone determination in human plasma by LC-MS/MS.
Meunier C; Blondelle D; Faure P; Baguet JP; Le Goff C; Chabre O; Ducros V
Clin Chim Acta; 2015 Jul; 447():8-15. PubMed ID: 25982778
[TBL] [Abstract][Full Text] [Related]
19. Sensitive determination of a drug candidate in dried blood spots using a TLC-MS interface integrated into a column-switching LC-MS/MS system.
Heinig K; Wirz T; Gajate-Perez A
Bioanalysis; 2010 Nov; 2(11):1873-82. PubMed ID: 21083495
[TBL] [Abstract][Full Text] [Related]
20. The importance of choosing the appropriate matrix to validate a bioanalytical method according to the study needs.
Lachance S; Lévesque A
Bioanalysis; 2014; 6(23):3101-11. PubMed ID: 25529879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
